Other Scientific | Medical Research Initiatives

The Broad Institute of MIT and Harvard

In June 2003, in an unprecedented partnership with the Massachusetts Institute of Technology, Harvard University and Whitehead Institute, the Broads announced the founding gift to create The Eli and Edythe Broad Institute for biomedical research. The Institute’s aim is to realize the promise of the human genome to revolutionize clinical medicine and to make knowledge freely available to scientists around the world.

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA

In 2007, The Eli and Edythe Broad Foundation provided $20 million to the UCLA Institute for Stem Cell Biology and Medicine to fund adult and embryonic stem cell research, enhancing a program that brings together biologists, chemists, engineers, geneticists and other scientists to develop new and more effective treatments for cancer, HIV/AIDS, Parkinson’s, metabolic disorders and other medical conditions. The gift funds the purchase of specialized, high-tech laboratory equipment and supports faculty recruitment through research grants and endowed professorships.

The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of USC

In 2007, The Eli and Edythe Broad Foundation committed $30 million toward the construction of center for stem cell research as part of the Health Sciences Campus of USC. This founding gift enables the creation of an approximately 80,000-square-foot building with state-of-the-art research laboratories and offices. The center will serve to foster collaboration between translational research and technology groups to turn stem cell discoveries into therapies.

The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF

The Eli and Edythe Broad Foundation committed $25 million in 2008 to create a center to accelerate the development of stem cell research at the University of California, San Francisco. The Broad Center will support cross-campus collaborations for the research of specific diseases, with disease-oriented teams led by a stem cell investigator and clinician-scientist. The ultimate goal is the translation of stem cell research into the therapy of common diseases.